Basis: FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters. Source: stored company filings and market data; unavailable inputs remain N/A.
The P/S ratio is N/A as of 2026-10-06T14:52:12.027Z.
Calculation as of: 2026-10-06T14:52:12.027Z.
Quote observation: 2026-10-06T14:50:23.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: e02887d9f7d553dead588493e3d1cc1cda6164751857f77264c258b40fe63259
Current P/S: FMP quote market capitalization / TTM revenue. Historical estimates use price and reported weighted-average shares; daily points use adjusted close × quarterly weighted-average shares / TTM revenue. Historical series through 2025-07-29.
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
PS RATIO
N/A
PS RATIO AVG TTM
3.84
PS RATIO AVG 3Y
62.72
PS RATIO AVG 5Y
40.92
PS RATIO AVG 10Y
N/A
PS RATIO AVG 15Y
N/A
PS RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Market Cap
$284.12M
PS Ratio
11.13
TTM Avg
341.11
3Y Avg
260.22
5Y Avg
137.39
Market Cap
$290.70M
PS Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$301.25M
PS Ratio
N/A
TTM Avg
995.02
3Y Avg
3050.37
5Y Avg
3251.65
| NAME | MARKET CAP | PS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Fulcrum Therapeutics, Inc. (FULC) | $281.92M | N/A | 3.84 | 62.72 | 40.92 |
| Abeona Therapeutics Inc. (ABEO)vs › | $284.12M | 11.13 | 341.11 | 260.22 | 137.39 |
| Larimar Therapeutics, Inc. (LRMR)vs › | $287.24M | N/A | N/A | N/A | N/A |
| Aurora Cannabis Inc. (ACB)vs › | $276.57M | 1.33 | 0.91 | 1.11 | 1.80 |
| BridgeBio Oncology Therapeutics Inc. (BBOT)vs › | $290.70M | N/A | N/A | N/A | N/A |
| Standard BioTools Inc. (LAB)vs › | $289.25M | 3.42 | 4.15 | 3.74 | 2.89 |
| Indaptus Therapeutics, Inc. (INDP)vs › | $272.91M | N/A | N/A | N/A | N/A |
| Fate Therapeutics, Inc. (FATE)vs › | $274.50M | 42.29 | 30.89 | 23.00 | 28.64 |
| Benitec Biopharma Inc. (BNTC)vs › | $301.25M | N/A | 995.02 | 3050.37 | 3251.65 |
| EyePoint Pharmaceuticals, Inc. (EYPT)vs › | $263.68M | 94.54 | 82.20 | 35.74 | 24.54 |
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q3 FY2025Period ended 2025-09-30 | $0 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-10-29 |
| Q4 FY2025Period ended 2025-12-31 | $0 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-02-24 |
| Q1 FY2026Period ended 2026-03-31 | $0 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-04-27 |
| Q2 FY2026Period ended 2026-06-30 | $0 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-07-30 |
| TTM revenue | $0 |
The current P/S calculation cannot be reconciled from the stored quote and revenue inputs.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
P/S Ratio
N/A
Market Cap / Trailing Twelve-Month Revenue
PS Ratio = Market Cap / Revenue (TTM)
The price-to-sales ratio compares market capitalization to trailing revenue. It is useful for valuing companies with little or no earnings.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | PS RATIO |
|---|---|
| 2025-07-29 | 5.93 |
| 2025-07-28 | 6.10 |
| 2025-07-25 | 6.10 |
| 2025-07-24 | 6.11 |
| 2025-07-23 | 6.18 |
| 2025-07-22 | 5.51 |
| 2025-07-21 | 5.55 |
| 2025-07-18 | 5.97 |
| 2025-07-17 | 6.20 |
| 2025-07-16 | 6.15 |
| 2025-07-15 | 6.12 |
| 2025-07-14 | 6.17 |
| 2025-07-11 | 6.12 |
| 2025-07-10 | 6.26 |
| 2025-07-09 | 6.18 |
| 2025-07-08 | 6.13 |
| 2025-07-07 | 5.48 |
| 2025-07-03 | 5.40 |
| 2025-07-02 | 5.41 |
| 2025-07-01 | 5.34 |
| 2025-06-30 | 5.37 |
| 2025-06-27 | 5.55 |
| 2025-06-26 | 5.76 |
| 2025-06-25 | 5.59 |
| 2025-06-24 | 5.62 |
| 2025-06-23 | 5.60 |
| 2025-06-20 | 5.47 |
| 2025-06-18 | 4.97 |
| 2025-06-17 | 5.02 |
| 2025-06-16 | 5.31 |
| 2025-06-13 | 5.35 |
| 2025-06-12 | 5.30 |
| 2025-06-11 | 5.33 |
| 2025-06-10 | 5.39 |
| 2025-06-09 | 5.56 |
| 2025-06-06 | 5.66 |
| 2025-06-05 | 5.55 |
| 2025-06-04 | 5.49 |
| 2025-06-03 | 5.50 |
| 2025-06-02 | 5.44 |
| 2025-05-30 | 5.37 |
| 2025-05-29 | 5.52 |
| 2025-05-28 | 5.39 |
| 2025-05-27 | 4.96 |
| 2025-05-23 | 5.03 |
| 2025-05-22 | 4.78 |
| 2025-05-21 | 4.88 |
| 2025-05-20 | 5.08 |
| 2025-05-19 | 5.41 |
| 2025-05-16 | 5.37 |
| 2025-05-15 | 5.15 |
| 2025-05-14 | 4.40 |
| 2025-05-13 | 4.52 |
| 2025-05-12 | 4.44 |
| 2025-05-09 | 4.19 |
| 2025-05-08 | 4.23 |
| 2025-05-07 | 3.96 |
| 2025-05-06 | 4.18 |
| 2025-05-05 | 4.48 |
| 2025-05-02 | 4.39 |
| 2025-05-01 | 2.95 |
| 2025-04-30 | 2.60 |
| 2025-04-29 | 2.46 |
| 2025-04-28 | 2.41 |
| 2025-04-25 | 2.38 |
| 2025-04-24 | 2.37 |
| 2025-04-23 | 2.42 |
| 2025-04-22 | 2.46 |
| 2025-04-21 | 2.33 |
| 2025-04-17 | 2.22 |
| 2025-04-16 | 2.06 |
| 2025-04-15 | 2.05 |
| 2025-04-14 | 1.97 |
| 2025-04-11 | 1.81 |
| 2025-04-10 | 1.77 |
| 2025-04-09 | 1.94 |
| 2025-04-08 | 1.78 |
| 2025-04-07 | 1.83 |
| 2025-04-04 | 1.69 |
| 2025-04-03 | 1.72 |
| 2025-04-02 | 1.91 |
| 2025-04-01 | 1.86 |
| 2025-03-31 | 1.94 |
| 2025-03-28 | 2.03 |
| 2025-03-27 | 2.08 |
| 2025-03-26 | 2.04 |
| 2025-03-25 | 2.10 |
| 2025-03-24 | 2.16 |
| 2025-03-21 | 2.12 |
| 2025-03-20 | 2.04 |
| 2025-03-19 | 2.00 |
| 2025-03-18 | 2.04 |
| 2025-03-17 | 2.10 |
| 2025-03-14 | 2.10 |
| 2025-03-13 | 1.96 |
| 2025-03-12 | 2.04 |
| 2025-03-11 | 2.00 |
| 2025-03-10 | 2.00 |
| 2025-03-07 | 2.12 |
| 2025-03-06 | 2.17 |
| 2025-03-05 | 2.19 |
| 2025-03-04 | 2.21 |
| 2025-03-03 | 2.19 |
| 2025-02-28 | 2.42 |
| 2025-02-27 | 2.27 |
| 2025-02-26 | 2.24 |
| 2025-02-25 | 2.86 |
| 2025-02-24 | 2.86 |
| 2025-02-21 | 2.97 |
| 2025-02-20 | 2.97 |
| 2025-02-19 | 2.96 |
| 2025-02-18 | 2.91 |
| 2025-02-14 | 2.85 |
| 2025-02-13 | 2.86 |
| 2025-02-12 | 2.75 |
| 2025-02-11 | 2.65 |
| 2025-02-10 | 2.80 |
| 2025-02-07 | 2.85 |
| 2025-02-06 | 2.96 |
| 2025-02-05 | 3.02 |
| 2025-02-04 | 2.95 |
| 2025-02-03 | 2.94 |
| 2025-01-31 | 3.06 |
| 2025-01-30 | 3.23 |
| 2025-01-29 | 3.15 |
| 2025-01-28 | 3.13 |
| 2025-01-27 | 3.16 |
| 2025-01-24 | 3.21 |
| 2025-01-23 | 3.19 |
| 2025-01-22 | 3.16 |
| 2025-01-21 | 3.09 |
| 2025-01-17 | 3.06 |
| 2025-01-16 | 3.07 |
| 2025-01-15 | 3.16 |
| 2025-01-14 | 3.13 |
| 2025-01-13 | 3.22 |
| 2025-01-10 | 3.37 |
| 2025-01-08 | 3.46 |
| 2025-01-07 | 3.77 |
| 2025-01-06 | 3.80 |
| 2025-01-03 | 3.92 |
| 2025-01-02 | 3.74 |
| 2024-12-31 | 3.63 |
| 2024-12-30 | 3.61 |
| 2024-12-27 | 3.70 |
| 2024-12-26 | 3.74 |
| 2024-12-24 | 3.51 |
| 2024-12-23 | 3.61 |
| 2024-12-20 | 3.36 |
| 2024-12-19 | 3.11 |
| 2024-12-18 | 3.26 |
| 2024-12-17 | 3.50 |
| 2024-12-16 | 3.41 |
| 2024-12-13 | 3.06 |
| 2024-12-12 | 3.11 |
| 2024-12-11 | 3.30 |
| 2024-12-10 | 3.13 |
| 2024-12-09 | 3.09 |
| 2024-12-06 | 3.08 |
| 2024-12-05 | 2.96 |
| 2024-12-04 | 2.71 |
| 2024-12-03 | 2.91 |
| 2024-12-02 | 2.99 |
| 2024-11-29 | 2.97 |
| 2024-11-27 | 3.05 |
| 2024-11-26 | 2.74 |
| 2024-11-25 | 2.65 |
| 2024-11-22 | 2.51 |
| 2024-11-21 | 2.29 |
| 2024-11-20 | 2.31 |
| 2024-11-19 | 2.32 |
| 2024-11-18 | 2.34 |
| 2024-11-15 | 2.32 |
| 2024-11-14 | 2.56 |
| 2024-11-13 | 2.77 |
| 2024-11-12 | 2.84 |
| 2024-11-11 | 2.84 |
| 2024-11-08 | 2.72 |
| 2024-11-07 | 2.71 |
| 2024-11-06 | 2.67 |
| 2024-11-05 | 2.59 |
| 2024-11-04 | 2.54 |
| 2024-11-01 | 2.50 |
| 2024-10-31 | 2.46 |
| 2024-10-30 | 2.52 |
| 2024-10-29 | 2.52 |
| 2024-10-28 | 2.52 |
| 2024-10-25 | 2.48 |
| 2024-10-24 | 2.52 |
| 2024-10-23 | 2.53 |
| 2024-10-22 | 2.64 |
| 2024-10-21 | 2.73 |
| 2024-10-18 | 2.73 |
| 2024-10-17 | 2.77 |
| 2024-10-16 | 2.82 |
| 2024-10-15 | 2.85 |
| 2024-10-14 | 2.78 |
| 2024-10-11 | 2.71 |
| 2024-10-10 | 2.55 |
| 2024-10-09 | 2.66 |
| 2024-10-08 | 2.76 |
| 2024-10-07 | 2.78 |
| 2024-10-04 | 2.98 |
| 2024-10-03 | 2.86 |
| 2024-10-02 | 3.01 |
| 2024-10-01 | 2.80 |
| 2024-09-30 | 2.78 |
| 2024-09-27 | 2.94 |
| 2024-09-26 | 3.12 |
| 2024-09-25 | 2.70 |
| 2024-09-24 | 2.50 |
| 2024-09-23 | 2.49 |
| 2024-09-20 | 2.62 |
| 2024-09-19 | 2.69 |
| 2024-09-18 | 2.68 |
| 2024-09-17 | 2.72 |
| 2024-09-16 | 2.48 |
| 2024-09-13 | 2.48 |
| 2024-09-12 | 2.68 |
| 2024-09-11 | 6.89 |
| 2024-09-10 | 6.57 |
| 2024-09-09 | 6.72 |
| 2024-09-06 | 6.65 |
| 2024-09-05 | 6.72 |
| 2024-09-04 | 6.43 |
| 2024-09-03 | 6.31 |
| 2024-08-30 | 6.66 |
| 2024-08-29 | 6.81 |
| 2024-08-28 | 6.91 |
| 2024-08-27 | 6.90 |
| 2024-08-26 | 7.59 |
| 2024-08-23 | 7.14 |
| 2024-08-22 | 6.85 |
| 2024-08-21 | 7.43 |
| 2024-08-20 | 7.34 |
| 2024-08-19 | 7.28 |
| 2024-08-16 | 7.20 |
| 2024-08-15 | 7.55 |
| 2024-08-14 | 7.03 |
| 2024-08-13 | 7.14 |
| 2024-08-12 | 7.02 |
| 2024-08-09 | 6.90 |
| 2024-08-08 | 6.97 |
| 2024-08-07 | 6.46 |
| 2024-08-06 | 6.91 |
| 2024-08-05 | 6.59 |
| 2024-08-02 | 7.44 |
| 2024-08-01 | 7.02 |
| 2024-07-31 | 229.17 |
| 2024-07-30 | 207.68 |
| 2024-07-29 | 208.18 |
| 2024-07-26 | 219.29 |
| 2024-07-25 | 213.36 |
| 2024-07-24 | 211.39 |
| 2024-07-23 | 218.30 |
| 2024-07-22 | 212.38 |
| 2024-07-19 | 197.56 |
| 2024-07-18 | 200.52 |
| 2024-07-17 | 206.45 |
| 2024-07-16 | 213.86 |
Showing the most recent 260 of 1,281 data points. The chart above shows the full history.
